Intellectual Property Magazine
Regeneron Pharmaceuticals Inc v Kymab Ltd
Supreme Court of the UK - 24 June 2020
By a 4:1 majority decision, the UK Supreme Court recently ruled that two Regeneron patents relating to transgenic mice are
invalid for insufficiency. The decision is a reversal of that of the Court of Appeal.